CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 202 enrolled
Drug / intervention
Psychosocial treatment plus Suboxone pharmacotherapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00591617
NCT00591617N/ACompleted
CompareCT.gov

Optimizing Outcomes Using Suboxone for Opiate Dependence

University of California, Los Angeles·interventional·Posted Jan 11, 2008·Updated Jan 29, 2013

In Brief

A clinical study evaluating Psychosocial treatment plus Suboxone pharmacotherapy for Opioid Dependency. Completed, enrolled 202 participants across 1 site.

Detailed Summary

Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Dependency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 11, 2008
Enrollment StartSep 1, 2006
Primary CompletionJan 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 18.5 years ago

Interventions

Psychosocial treatment plus Suboxone pharmacotherapyother

Participants randomly assigned to one of four psychosocial treatment conditions building on pharmacotherapy with Suboxone (buprenorphine + naloxone)